Evaluation of Micronucleus Count in Oral Squamous Cell Carcinoma (OSCC) Newly Diagnosed Patients Compared to Previously Treated Ones: A Cytologic Study
Marjan Mohammadi, Noushin Jalayer Naderi, Ata Garajei, Seyed Masoud Sajedi · 2025
Read Evaluation of Micronucleus Count in Oral Squamous Cell Carcinoma (OSCC) Newly Diagnosed Patients Compared to Previously Treated Ones: A Cytologic Study by Marjan Mohammadi, Noushin Jalayer Naderi, Ata Garajei, Seyed Masoud Sajedi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12881716.txt.
Description
Mohammadi, Naderi, Garajei, and Sajedi count micronuclei in mouth cancer patients, in work from twenty twenty-five. Micronuclei are small extra nuclei in cells that signal genetic damage. Counting them in scraped cheek cells is a simple, painless biomarker of that damage.
Cheek cells came from two groups of oral squamous cell carcinoma patients: newly diagnosed patients and previously treated ones. Seventeen newly diagnosed patients formed one group. Comparing counts shows whether treatment adds genomic damage or whether cancer itself drives it. Monitoring damage this way could help track therapy effects and relapse risk over time.
Catalog record
| CREATOR | Marjan Mohammadi, Noushin Jalayer Naderi, Ata Garajei, Seyed Masoud Sajedi |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |